These findings further support that the disruption of the NAD+/NADP+ balance caused by NFATc1 inhibition reduces the flux through the PPP, thereby decreasing the production of biosynthetic precursors essential for new cell generation and ultimately inhibiting tumor cell proliferation. Here, NFATC1 is linked to neoplasm.